Search Results for: depression

June 16, 2019June 16, 2019

Depression Called a’Core Symptom’ of MS

Publication date: Jun 14, 2019 Authors: Kalkan S, Jaffe WI, Simma-Chiang V, Li ESW, Blaivas JG Abstract INTRODUCTION: There is a paucity of data about augmentation cystoplasty (AC) in multiple ... Read more

June 15, 2019June 15, 2019

Solving the Opioid Crisis: Respiratory Depression by Opioids as Critical Endpoint.

Opioids Literature

Publication date: Jun 10, 2019 Opioid overdose is due to misuse of prescription pain killers such as oxycodone, as well as misuse of street drugs like heroin or fentanyl. Opioid ... Read more

June 7, 2019June 7, 2019

Anxiety and depression in patients with multiple sclerosis: The mediating effects of perceived social support.

Multiple Sclerosis Literature

Publication date: Jan 01, 2019 Social support has been identified as a buffering or intervening variable in stressful life events. Research has demonstrated that greater social support is associated with ... Read more

June 6, 2019June 6, 2019

Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.

Opioids Literature

Publication date: Jun 05, 2019 Although mu-opioid receptor agonists have been the mainstay of analgesic regimens for moderate to severe pain, they are associated with serious side effects, risks, and ... Read more

June 1, 2019June 1, 2019

Study sheds light on design of pharmacological strategies to treat depression in Huntington’s disease

Huntington's Disease News

Publication date: Jun 01, 2019 An altered function of Cdk5 kinase -an essential enzyme in several cell signaling pathways- could explain the physiopathology of the depressive-like behavior in Huntington’s disease, ... Read more

May 24, 2019May 24, 2019

Modifiable factors associated with depression and anxiety in multiple sclerosis.

Multiple Sclerosis Literature

Publication date: May 23, 2019 Modifiable lifestyle factors are implicated in multiple sclerosis (MS) symptoms but their role in mood is unclear. This study aims to investigate associations between lifestyle ... Read more

$Safety of Electroconvulsive Therapy in Treatment-Refractory Depression in the Setting of Multiple Sclerosis.$

May 24, 2019May 24, 2019

Safety of Electroconvulsive Therapy in Treatment-Refractory Depression in the Setting of Multiple Sclerosis.

Multiple Sclerosis Literature

Publication date: May 14, 2019 Oilgmueller, J., Sharma, A., Egbert, M., and , Tran. Safety of Electroconvulsive Therapy in Treatment-Refractory Depression in the Setting of Multiple Sclerosis. 18071. 2019 J ... Read more

May 20, 2019May 20, 2019

Opioid-Induced Sedation and Respiratory Depression: Are Sedation Scales Enough to Prevent Adverse Drug Events Postoperatively?

Opioids Literature

Publication date: May 15, 2019 Nurses who care for hospitalized patients are responsible for ensuring adequate pain management is provided in a safe manner. The clinical challenge is balancing the ... Read more

May 17, 2019May 17, 2019

Implementing a Clinical Practice Guideline on Opioid-Induced Advancing Sedation and Respiratory Depression.

Opioids Literature

Publication date: May 14, 2019 Opioid-induced respiratory depression (OIRD) is a serious adverse reaction associated with opioid administration. The purpose of this quality improvement study was to evaluate the impact ... Read more

May 15, 2019May 15, 2019

Longitudinal Association Between Depression and Inflammatory Markers: Results From the Netherlands Study of Depression and Anxiety.

Precision Medicine Literature

Publication date: May 15, 2019 While cross-sectional associations of inflammatory markers interleukin-6 (IL-6) and C-reactive protein with major depressive disorder are well established, evidence for longitudinal associations mostly comes from ... Read more